2
Registered trials
0
Recruiting
2
Unique sponsors
2
Unique IMPs
1
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
B
Haematology (ATC B)
1
Mechanism of action (INN-stem analysis)
Antiplatelet / NSAID
1 substance
Factor Xa inhibitor (DOAC)
1 substance
Phase IV:
1
Phase I (Other):
1
Phase IV
1 trial-
EndedUniversity Of Ottawa Heart Institute AcademicACETYLSALICYLIC ACID; RIVAROXABAN
Phase I (Other)
1 trial-
EndedBayer AG CommercialIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Bayer AG | Commercial | 1 | Phase I (Other) | 0 |
| University Of Ottawa Heart Institute | Academic | 1 | Phase IV | 0 |
New trials by year
2024
1